City
Epaper

IIT-Hyderabad develops oral tablets for black fungus

By Lokmat English Desk | Updated: May 30, 2021 12:58 IST

Researchers at the Indian Institute of Technology, Hyderabad (IIT-H), have approved the mass production of an oral solution to ...

Open in App

Researchers at the Indian Institute of Technology, Hyderabad (IIT-H), have approved the mass production of an oral solution to treat black fungus, providing huge relief to patients. After two years of study, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production. The oral solution will ensure easy medicare for patients and also affordable with a 60 mg tablet likely to cost ₹200 only. At present, Kala Azar (visceral leishmaniasis) treatment is being used for black fungus and other fungus in the country but its availability, affordability and the procedures involved make it imperative to allow emergency and immediate trial of this oral drug, feels the team of Prof. Saptarshi Majumdar and Dr. Chandra Shekhar Sharma and their Ph.D scholars Mrunalini Gaydhane and Anindita Laha, who have been working on the oral solution for the last two years.

According to IIT-H, Prof. Saptarshi Majumdar and Dr. Chandra Shekhar Sharma from the Department of Chemical Engineering made a proven study in 2019 about oral nanofibrous Amphotericin B (AmB) to be effective for Kala Azar. This was the first attempt to fabricate nanofibrous oral tablets of Amphotericin B (AmB) for the potential cure of Leishmaniasis or Kala Azar.The purpose was to increase the drug absorption and reduce aggregation, to lower the drug toxicity. For this, the team selected gelatin, an FDA-approved polymer as an excipient for drug molecules. They explaining the reason for oral administration not preferred earlier despite the comfortable and effective route. The researchers said that due to its amphiphilic nature, the AmB has poor aqueous solubility and forms aggregates in the system, which stresses renal filtration and thus causing nephrotoxicity (adverse impact of medicines on the kidney). Dr. Chandra Shekhar Sharma, Associate Professor, Department of Chemical Engineering Sharma said that since the idea behind the research was to find a solution to serve society, the oral solution developed is made free from intellectual property so that it can be mass produced and is made affordable and available to all. Amid rising cases of mucormycosis, another consignment of AmBisome (Amphotericin B injection), used to treat black fungus reached India on Sunday. Vietnam has discovered a new, stealthier Covid-19 variant which spreads quickly by air and is a combination of variants first identified in India and the UK, the Guardian reported.

 

Tags: Black fungusCoronavirus
Open in App

Related Stories

TechnologyNew Covid Wave Could Peak by August-End in South Korea; Government Strengthens Response Measures

HealthCOVID-19: Only 2% of Patients Develop Autoantibodies After Recovery, Study Reveals

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

HealthGood News! Scientists Develop All-in-One Vaccine Effective Against Current and Future Coronavirus Variants

National Realted Stories

NationalKarnataka BJP MLA's 'violent' remarks against Robert Vadra trigger row

NationalIAF confirms object falling from sky on MP house as 'non-explosive store'; probe initiated

NationalRahul Gandhi, Congress should apologise for derogatory remarks against Savarkar: BJP's Ram Kadam

NationalTripura CM Saha holds key meeting with BJP, IPFT and TMP leaders

NationalPahalgam terror attack: Rajkot airport goes 24/7 as Pak shuts airspace for Indian flights